No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ASICAtegrity Specialty Holdings LLC | 884.91M | 18.41 | 19.18 | 42.48% | 14.98% | 9.58% | 14.19% | |
| SKWDSkyward Specialty Insurance Group, Inc. | 2.05B | 46.48 | 16.20 | 28.17% | 10.55% | 14.69% | 14.66% | 0.15 |
| Dec 2023 | Dec 2024 | |
|---|---|---|
| Revenue | 241.32M | 343.83M |
| Revenue Growth % | - | 0.42% |
| Medical Costs & Claims | 200.31M | 235.93M |
| Medical Cost Ratio % | - | - |
| Gross Profit | 41.01M | 107.91M |
| Gross Margin % | - | - |
| Gross Profit Growth % | - | 1.63% |
| Operating Expenses | 28.39M | 41.64M |
| OpEx / Revenue % | - | - |
| Depreciation & Amortization | 227K | 699K |
| Combined Ratio % | - | - |
| Operating Income | 12.62M | 66.26M |
| Operating Margin % | - | - |
| Operating Income Growth % | - | 4.25% |
| EBITDA | 12.85M | 66.96M |
| EBITDA Margin % | - | - |
| Interest Expense | 2.24M | 2.04M |
| Non-Operating Income | -2.24M | -2.04M |
| Pretax Income | 12.62M | 66.26M |
| Pretax Margin % | - | - |
| Income Tax | 2.52M | 12.32M |
| Effective Tax Rate % | - | - |
| Net Income | 10.05M | 47.09M |
| Net Margin % | - | - |
| Net Income Growth % | - | 3.69% |
| EPS (Diluted) | 0.21 | 0.96 |
| EPS Growth % | - | 3.57% |
| EPS (Basic) | 0.21 | 1.00 |
| Diluted Shares Outstanding | 48.46M | 48.46M |
| Dec 2023 | Dec 2024 | |
|---|---|---|
| Total Assets | 882.04M | 1.12B |
| Asset Growth % | - | 0.27% |
| Total Investment Assets | 352.94M | 761.89M |
| Long-Term Investments | 352.25M | 761.61M |
| Short-Term Investments | 98.2M | 491.36M |
| Total Current Assets | 0 | 0 |
| Cash & Equivalents | 264.65M | 26.57M |
| Receivables | 1000K | 1000K |
| Other Current Assets | -463.7M | -657.05M |
| Goodwill & Intangibles | 0 | 0 |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| PP&E (Net) | 0 | 0 |
| Other Assets | -352.25M | -761.61M |
| Total Liabilities | 559.85M | 724.63M |
| Total Debt | 0 | 0 |
| Net Debt | -264.65M | -26.57M |
| Long-Term Debt | 0 | 0 |
| Short-Term Debt | 0 | 0 |
| Total Current Liabilities | 0 | 0 |
| Accounts Payable | 33.57M | 74.41M |
| Deferred Revenue | 0 | 0 |
| Other Current Liabilities | -42.42M | -100.9M |
| Deferred Taxes | 0 | 0 |
| Other Liabilities | 0 | 0 |
| Total Equity | 322.2M | 398.81M |
| Equity Growth % | - | 0.24% |
| Shareholders Equity | 321.7M | 398.31M |
| Minority Interest | 500K | 500K |
| Retained Earnings | -12.52M | 34.57M |
| Common Stock | 338.63M | 360.74M |
| Accumulated OCI | -4.42M | 3M |
| Return on Equity (ROE) | 0.03% | 0.13% |
| Return on Assets (ROA) | 0.01% | 0.05% |
| Equity / Assets | - | - |
| Debt / Equity | - | - |
| Book Value per Share | 6.65 | 8.23 |
| Tangible BV per Share | - | - |
| Dec 2023 | Dec 2024 | |
|---|---|---|
| Cash from Operations | 85.71M | 125.61M |
| Operating CF Growth % | - | 0.47% |
| Operating CF / Revenue % | - | - |
| Net Income | 10.1M | 53.95M |
| Depreciation & Amortization | 227K | 699K |
| Stock-Based Compensation | 27K | 2.01M |
| Deferred Taxes | 0 | 0 |
| Other Non-Cash Items | 3K | -34.83M |
| Working Capital Changes | 75.35M | 103.79M |
| Cash from Investing | 14.51M | -363.27M |
| Capital Expenditures | 0 | 0 |
| Acquisitions | 0 | 0 |
| Purchase of Investments | -194.94M | -482.23M |
| Sale/Maturity of Investments | 1000K | 1000K |
| Other Investing | -474K | 251K |
| Cash from Financing | 32.27M | -414K |
| Dividends Paid | -2.73M | -414K |
| Share Repurchases | 0 | -414K |
| Stock Issued | 35M | 0 |
| Debt Issuance (Net) | 0 | 0 |
| Other Financing | 0 | 414K |
| Net Change in Cash | 132.49M | -238.07M |
| Exchange Rate Effect | 0 | 0 |
| Cash at Beginning | 132.15M | 264.65M |
| Cash at End | 264.65M | 26.57M |
| Free Cash Flow | 85.71M | 125.61M |
| FCF Growth % | - | 0.47% |
| FCF Margin % | - | - |
| FCF per Share | 1.77 | 2.59 |
| Metric | 2023 | 2024 |
|---|---|---|
| Combined Ratio | 94.77% | 80.73% |
| Medical Cost Ratio | 83.01% | 68.62% |
| Return on Equity (ROE) | 3.12% | 13.06% |
| Return on Assets (ROA) | 1.14% | 4.7% |
| Equity / Assets | 36.53% | 35.5% |
| Book Value / Share | 6.65 | 8.23 |
| Revenue Growth | - | 42.48% |
Ategrity Specialty Holdings LLC (ASIC) has a price-to-earnings (P/E) ratio of 19.2x. This is roughly in line with market averages.
Ategrity Specialty Holdings LLC (ASIC) grew revenue by 42.5% over the past year. This is strong growth.
Yes, Ategrity Specialty Holdings LLC (ASIC) is profitable, generating $56.5M in net income for fiscal year 2024 (13.7% net margin).
Ategrity Specialty Holdings LLC (ASIC) does not currently pay a meaningful dividend. The company may be reinvesting profits for growth.
Ategrity Specialty Holdings LLC (ASIC) has a return on equity (ROE) of 13.1%. This is reasonable for most industries.
Ategrity Specialty Holdings LLC (ASIC) has a combined ratio of 80.7%. A ratio below 100% indicates underwriting profitability.